Studies on the Metabolic Fate of Amrubicin Hydrochloride (SM-5887), a Novel Antitumor Agent. (III): Blood Concentration, Distribution, Metabolism and Excretion after a Single Intravenous Administration to Dogs.
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.